Latest Strategy Changes News

Red Hawk Mining has made significant progress on its Blacksmith Iron Ore Project, submitting a mining proposal and reporting positive sinter test results, while managing tight cash reserves through asset sales and loan negotiations.

CAQ Holdings Limited reported an 8% decrease in leasing revenue for the December 2024 quarter, as tenant negotiations continue amid uncertain government policies affecting the Hainan free trade port development.

Michael Hill International reports a 24% drop in comparable EBIT for FY25H1 amid challenging conditions, yet margin improvements and digital growth offer a silver lining.

IPB Petroleum has appointed a new chairman and is intensifying efforts to secure funding for drilling its key Browse Basin assets, while maintaining a strong cash position and exploring new project opportunities.

SportsHero Limited has arranged a $1 million unsecured loan facility to support its working capital needs, with flexible monthly drawdowns and a fixed 10% interest rate. The company has already drawn $100,000 from this facility, signaling ongoing liquidity management efforts.

Regional Express Holdings has completed the transfer of debt from PAGAC Regulus Holding to the Commonwealth of Australia, marking a key step in its ongoing administration process.

Connected Minerals Ltd has successfully raised $5.1 million to fuel its aggressive uranium exploration in Namibia, reporting impressive high-grade rock chip results that set the stage for maiden drilling in early 2025.

Discovery Alaska Limited is actively assessing new project opportunities and reviewing strategies for its key Alaskan gold assets, while maintaining cautious financial management with limited cash reserves.

Falcon Metals reports steady progress across its Victorian and Western Australian projects, maintaining a strong cash position to fuel ongoing exploration in 2025.

Neometals Ltd has bolstered its financial position with a A$7.1 million capital raise while progressing key projects including the commissioning of a lithium-ion battery recycling plant in Germany and preparing for maiden gold drilling at Barrambie.

InhalerX Limited reported a negative cash flow for the December quarter despite securing a substantial $38.5 million funding facility aimed at advancing its clinical trials. The company has yet to draw on this facility, maintaining a cautious cash position as it progresses its drug development programs.

InhaleRx has locked in a $38.5 million funding deal with Clendon Biotech Capital, enabling expanded Phase 2 trials for its inhaled breakthrough cancer pain and panic disorder treatments. The company also filed a key international patent, positioning itself for a faster path to FDA approval.